Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Fowler

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Blood|October 5, 2013
Doubling down on PKC benefits allogeneic BMTDaniel H Fowler
Immunological Reviews|December 17, 2013
Rapamycin-resistant effector T-cell therapyDaniel H Fowler
Journal of Leukocyte Biology|August 2, 2012
Editorial: protean effects of IL-10 include skin self-defenseDaniel H Fowler
Critical Reviews in Oncology/Hematology|October 7, 2005
Shared biology of GVHD and GVT effects: potential methods of separationDaniel H Fowler
Blood|February 4, 2017
IL-27: a new target for GVHD preventionDaniel H Fowler, Shoba Amarnath
Ebiomedicine|March 17, 2016
T memory stem cell formation: Caveat mTORDaniel H Fowler, Luca Gattinoni
Immunotherapy|December 14, 2011
Harnessing autophagy for adoptive T-cell therapyShoba Amarnath, Daniel H Fowler
Hematology. American Society of Hematology. Education Program|December 13, 2012
Are we making progress in GVHD prophylaxis and treatment?Steven Z Pavletic, Daniel H Fowler
Blood|May 10, 2008
"Regulating" rheumatoid arthritis via autotransplantationSteven Z Pavletic, Daniel H Fowler
Journal of Cellular Biochemistry. Supplement|June 6, 2002
Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issuesJeffrey A Medin, Daniel H Fowler
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Blood|October 5, 2013
Doubling down on PKC benefits allogeneic BMTDaniel H Fowler
Immunological Reviews|December 17, 2013
Rapamycin-resistant effector T-cell therapyDaniel H Fowler
Journal of Leukocyte Biology|August 2, 2012
Editorial: protean effects of IL-10 include skin self-defenseDaniel H Fowler
Critical Reviews in Oncology/Hematology|October 7, 2005
Shared biology of GVHD and GVT effects: potential methods of separationDaniel H Fowler
Blood|February 4, 2017
IL-27: a new target for GVHD preventionDaniel H Fowler, Shoba Amarnath
Ebiomedicine|March 17, 2016
T memory stem cell formation: Caveat mTORDaniel H Fowler, Luca Gattinoni
Immunotherapy|December 14, 2011
Harnessing autophagy for adoptive T-cell therapyShoba Amarnath, Daniel H Fowler
Hematology. American Society of Hematology. Education Program|December 13, 2012
Are we making progress in GVHD prophylaxis and treatment?Steven Z Pavletic, Daniel H Fowler
Blood|May 10, 2008
"Regulating" rheumatoid arthritis via autotransplantationSteven Z Pavletic, Daniel H Fowler
Journal of Cellular Biochemistry. Supplement|June 6, 2002
Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issuesJeffrey A Medin, Daniel H Fowler
Pageof 10